Literature DB >> 342553

Combined tricyclic-MAOI therapy for refractory depression: a review, with guidelines for appropriate usage.

R S Goldberg, W E Thornton.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 342553     DOI: 10.1002/j.1552-4604.1978.tb02435.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


× No keyword cloud information.
  6 in total

Review 1.  Adverse effects of antidepressant drugs. Part 2: 'Second generation' antidepressants and rational decision making in antidepressant therapy.

Authors:  B Blackwell
Journal:  Drugs       Date:  1981-04       Impact factor: 9.546

Review 2.  Adverse effects of antihypertensive drugs.

Authors:  F E Husserl; F H Messerli
Journal:  Drugs       Date:  1981-09       Impact factor: 9.546

3.  Minor and clinically non-significant interaction between toloxatone and amitriptyline.

Authors:  S Vandel; G Bertschy; M C Perault; M Sandoz; S Bouquet; R Chakroun; S Guibert; B Vandel
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 4.  Risk-benefit assessment of newer versus older monoamine oxidase (MAO) inhibitors.

Authors:  Y Lecrubier
Journal:  Drug Saf       Date:  1994-04       Impact factor: 5.606

5.  Controlled trial of trimipramine, monoamine oxidase inhibitors, and combined treatment in depressed outpatients.

Authors:  J P Young; M H Lader; W C Hughes
Journal:  Br Med J       Date:  1979-11-24

6.  Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).

Authors:  C J Fowler; M Eriksson; G Thorell; O Magnusson
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-10       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.